SCHEMBL8285340

SCHEMBL8285340

Cc1cc2c(c(OCC(=O)N3CCOCC3)n1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.45
KDM4E B2RXH2 3/20 0.43
ALDH1A1 P00352 3/20 0.43
HPGD P15428 1/20 0.43
HSD17B10 Q99714 1/20 0.43
PKM P14618 1/20 0.43
TP53 P04637 2/20 0.42
GLA P06280 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
GAA P10253 2/20 0.40
LMNA P02545 1/20 0.40
FKBP1A P62942 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
EGFR P00533 2/20 0.39
SCN5A Q14524 1/20 0.38
SCN9A Q15858 1/20 0.38
MAPT P10636 2/20 0.38
PIK3CD O00329 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287532 0.85 PDE11A (0.51) PDE11AKDM4EALDH1A1HPGDHSD17B10
SCHEMBL8286086 0.85 PDE11A (0.46) PDE11AKDM4EALDH1A1LMNASMN1; SMN2
SCHEMBL8286558 0.84 PDE11A (0.46) PDE11AKDM4EALDH1A1HPGDPKM
SCHEMBL8285339 0.83 KDM4E (0.46) KDM4EALDH1A1HPGDTP53L3MBTL1
SCHEMBL8285337 0.83 HSP90AA1 (0.47) PDE11AKDM4EALDH1A1HPGDPKM
SCHEMBL8286426 0.81 PDE11A (0.39) PDE11AKDM4EALDH1A1HPGDTP53
SCHEMBL8286076 0.80 PDE11A (0.39) PDE11AKDM4EALDH1A1HPGDTP53
SCHEMBL8286083 0.79 PDE11A (0.38) PDE11AKDM4EALDH1A1HPGDTP53
SCHEMBL8287237 0.79 PDE11A (0.43) PDE11AKDM4EALDH1A1HPGDHSD17B10
SCHEMBL8287403 0.79 PDE11A (0.56) PDE11AKDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed